Bioscience

Alzheimer’s prevention strategies remain an elusive challenge

May 26, 2010

By Flinn Foundation

[Source: Scientific American] – The search for new drugs that can reverse the course of Alzheimer’s has frustrated pharmaceutical companies, with several failures reported in recent years. Research advances have arrived, not in the form of new drugs but, rather, in technologies that track the underlying biology of the disease before the first symptoms appear.

The capacity to track things early underlines the growing recognition that the disease process begins many years before a diagnosis, a realization that has placed new emphasis on the need for preventive measures to ward off the leading cause of dementia.

For more information: Alzheimer’s Prevention Strategies Remain an Elusive Challenge